Literature DB >> 1613258

Enzyme immunoassay techniques. An overview.

T Porstmann1, S T Kiessig.   

Abstract

In spite of the great variety of enzyme immunoassays (EIA) they can be classified into two groups 'analyte-observed' and 'reagent-observed' assays, depending on their reaction principle. The latter are favored by use of monoclonal antibodies and are characterized by a greater sensitivity, a larger measuring range, a lower susceptibility to disturbing influences. They can be used only for detection of macromolecules. For heterogeneous EIAs to be used on laboratory scale, simple adsorption of antigens and antibodies is still recommendable though affinity constants decrease by at least one order of magnitude and antibody density at the solid phase and analyte binding capacity are not parallel due to increasing steric hindrance. For this reason, the antibody with the higher affinity constant should therefore always be used as solid-phase antibody. Microparticles used as solid phase for heterogeneous assays, due to their very high binding capacity for the analyte and extremely short diffusion distances, guarantee 'one step' assays of only a few minutes. Of the limited number of enzymes suitable as markers in immunoassays, horseradish peroxidase is the enzyme of choice followed by alkaline phosphatase. Although enzyme and enzyme-labelled reagents are detectable by fluorogenic product measuring with a sensitivity, which is 10-1000 times higher than using chromogenic substrates, the sensitivity of the assays can be increased only by factor 2-10. Labelling enzymes cannot only be covalently bound to the antibody, but also via anti-enzyme antibodies. Pros and cons of the different methods of coupling the enzyme/anti-enzyme complex to analyte-containing immune complexes are discussed. Different EIA variants to detect specific antibodies are reviewed. Among them only capture EIAs permit precise isotype analysis of antibodies of a distinct idiotype. Homogeneous EIAs are widely spread for hapten determination but even variants based on proximal linkage are no alternatives to heterogeneous EIAs for determination of macromolecules. Different parameters are defined which permit to assess the quality of an immunoassay and which should be used in routine assays as internal controls in the laboratory.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1613258     DOI: 10.1016/0022-1759(92)90061-w

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  61 in total

Review 1.  Inorganic Complexes and Metal-Based Nanomaterials for Infectious Disease Diagnostics.

Authors:  Christine F Markwalter; Andrew G Kantor; Carson P Moore; Kelly A Richardson; David W Wright
Journal:  Chem Rev       Date:  2018-12-04       Impact factor: 60.622

2.  Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models.

Authors:  Christopher M Acker; Stefanie K Forest; Ray Zinkowski; Peter Davies; Cristina d'Abramo
Journal:  Neurobiol Aging       Date:  2012-06-21       Impact factor: 4.673

3.  Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides.

Authors:  Michael M C Sun; Kevin S Beam; Charles G Cerveny; Kevin J Hamblett; Richard S Blackmore; Michael Y Torgov; Felicia G M Handley; Nathan C Ihle; Peter D Senter; Stephen C Alley
Journal:  Bioconjug Chem       Date:  2005 Sep-Oct       Impact factor: 4.774

Review 4.  Central nervous system drug development: an integrative biomarker approach toward individualized medicine.

Authors:  B Gomez-Mancilla; E Marrer; J Kehren; A Kinnunen; G Imbert; R Hillebrand; M Bergström; M E Schmidt
Journal:  NeuroRx       Date:  2005-10

5.  Critical ligand binding reagent preparation/selection: when specificity depends on reagents.

Authors:  Bonita Rup; Denise O'Hara
Journal:  AAPS J       Date:  2007-05-11       Impact factor: 4.009

6.  Molecular pincers: antibody-based homogeneous protein sensors.

Authors:  Ewa Heyduk; Benjamin Dummit; Yie-Hwa Chang; Tomasz Heyduk
Journal:  Anal Chem       Date:  2008-05-21       Impact factor: 6.986

Review 7.  Non-invasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood.

Authors:  Jaclyn A Freudenberg; Kathryn Bembas; Mark I Greene; Hongtao Zhang
Journal:  Methods       Date:  2008-06-23       Impact factor: 3.608

8.  Serotype 1-specific monoclonal antibody-based antigen capture immunoassay for detection of circulating nonstructural protein NS1: Implications for early diagnosis and serotyping of dengue virus infections.

Authors:  Hua Xu; Biao Di; Yu-xian Pan; Li-wen Qiu; Ya-di Wang; Wei Hao; Li-juan He; Kwok-yung Yuen; Xiao-yan Che
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

9.  Study of plasma adrenomedullin level in normal pregnancy and preclampsia.

Authors:  Azza Abo Senna; Magda Zedan; Gamal E Abd el-Salam; Ashraf I el-Mashad
Journal:  Medscape J Med       Date:  2008-02-06

10.  Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension.

Authors:  V Tahan; E Avsar; C Karaca; E Uslu; F Eren; S Aydin; H Uzun; H O Hamzaoglu; F Besisik; C Kalayci; A Okten; N Tozun
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.